Using the early marker h-FABP in an intelligent test design greatly eases the clinical challenge of triaging AMI patients:
- Detect AMI during the initial phase of the infarction.
- Take your treatment decision with a higher certainty
- Shorten the hospital stay for AMI negative patients
- Make your lab mobile. Our rapid test is quickly at hand when needed.
- Free yourself from opening hours and turnaround times of a central lab.
- Reduce complexity. Our tests come ready uo use.
- Facilitate focusing on the patient. No specialized knowledge required to perform the test.